These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25564369)

  • 1. Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012.
    Wei B; Blount BC; Xia B; Wang L
    J Expo Sci Environ Epidemiol; 2016; 26(3):249-56. PubMed ID: 25564369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
    Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
    Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.
    Ashley DL; O'Connor RJ; Bernert JT; Watson CH; Polzin GM; Jain RB; Hammond D; Hatsukami DK; Giovino GA; Cummings KM; McNeill A; Shahab L; King B; Fong GT; Zhang L; Xia Y; Yan X; McCraw JM
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1389-98. PubMed ID: 20501750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG; Borukhova A; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSNA Exposure: Levels of NNAL Among Canadian Tobacco Users.
    Czoli CD; Hammond D
    Nicotine Tob Res; 2015 Jul; 17(7):825-30. PubMed ID: 25481919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogen Exposure among Canadian Tobacco Users: Changes in NNK Exposure from 2007-2009 through 2012-2013.
    Czoli CD; Hammond D
    Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):262-267. PubMed ID: 29358222
    [No Abstract]   [Full Text] [Related]  

  • 7. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Muscat JE; Djordjevic MV; Colosimo S; Stellman SD; Richie JP
    Cancer; 2005 Apr; 103(7):1420-6. PubMed ID: 15726545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
    Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
    Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
    Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
    Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers.
    Murphy SE; Carmella SG; Idris AM; Hoffmann D
    Cancer Epidemiol Biomarkers Prev; 1994; 3(5):423-8. PubMed ID: 7920210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users.
    Hecht SS; Carmella SG; Stepanov I; Jensen J; Anderson A; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):732-5. PubMed ID: 18349296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers.
    Kavvadias D; Scherer G; Cheung F; Errington G; Shepperd J; McEwan M
    Biomarkers; 2009 Dec; 14(8):547-53. PubMed ID: 19747086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations.
    Vardavas CI; Fthenou E; Patelarou E; Bagkeris E; Murphy S; Hecht SS; Connolly GN; Chatzi L; Kogevinas M
    Tob Control; 2013 May; 22(3):194-200. PubMed ID: 22253001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).
    Xia B; Blount BC; Guillot T; Brosius C; Li Y; Van Bemmel DM; Kimmel HL; Chang CM; Borek N; Edwards KC; Lawrence C; Hyland A; Goniewicz ML; Pine BN; Xia Y; Bernert JT; De Castro BR; Lee J; Brown JL; Arnstein S; Choi D; Wade EL; Hatsukami D; Ervies G; Cobos A; Nicodemus K; Freeman D; Hecht SS; Conway K; Wang L
    Nicotine Tob Res; 2021 Feb; 23(3):573-583. PubMed ID: 32716026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolites of a tobacco-specific lung carcinogen in children exposed to secondhand or thirdhand tobacco smoke in their homes.
    Thomas JL; Guo H; Carmella SG; Balbo S; Han S; Davis A; Yoder A; Murphy SE; An LC; Ahluwalia JS; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1213-21. PubMed ID: 21467230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
    Benowitz N; Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2795-800. PubMed ID: 20805316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn.
    Florek E; Piekoszewski W; Basior A; Merritt AT; Mazela J; Lechowicz W; Kornacka MK; Kramer L
    J Physiol Pharmacol; 2011 Jun; 62(3):377-83. PubMed ID: 21893699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers.
    Stepanov I; Upadhyaya P; Carmella SG; Feuer R; Jensen J; Hatsukami DK; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1764-73. PubMed ID: 18628430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of a glucuronide conjugate of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats.
    Atawodi SE; Michelsen K; Richter E
    Arch Toxicol; 1994; 69(1):14-7. PubMed ID: 7717849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients.
    Lee HL; Hsueh YM; Chung CJ; Pu YS; Chang LW; Hsieh DP; Liou SH; Lin P
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3390-5. PubMed ID: 19064555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.